1.Clinical application of retrograde thyroidectomy from top to bottom in retrosternal thyroid surgery.
Jing WU ; Xiaohong LI ; Changyu YAO ; Daming WANG ; Yehai LIU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(12):1011-1018
Objective:To investigate the value of retrograde thyroidectomy from top to bottom in the operation of retrosternal thyroid surgery. Methods:Retrospective analysis was performed on the cases of retrosternal goiter excised by our surgeons from January 2017 to June 2022,the technical points, feasibility and advantages of the operation were summarized. Results:A total of 15 cases of retrosternal goiter treated by retrograde thyroidectomy were collected, including 5 cases of type Ⅰ retrosternal goiter and 10 cases of type Ⅱ retrosternal goiter.The postoperative pathology was benign. The surgical time is 40-60 minutes for unilateral retrosternal goiter and 70-90 minutes for bilateral goiter. All patients were discharged normally within 7 days after operation, and no operative complications were observed such as bleeding, hoarseness or hypoparathyroidism. Conclusion:This surgical excision method of thyroid is suitable for the type Ⅰ and type Ⅱ retrosternal goiter surgery, which can avoid the difficulties in exposing and separating the the inferior thyroid behind the sternum in conventional surgical method, speed up the operation and reduced the difficulty of operation, and has certain promotion value in clinic.
Humans
;
Thyroidectomy/methods*
;
Retrospective Studies
;
Goiter, Substernal/pathology*
;
Hypoparathyroidism/surgery*
2.Predictive value of PTH level on day 1 after surgery for papillary thyroid carcinoma in patients with permanent hypoparathyroidism.
Jinwei GAO ; Qi ZHANG ; Zesheng WANG ; Yibin GUO ; Shengchang LIANG ; Yupeng ZHANG ; Kunpeng QU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(5):365-369
Objective:To investigate the relationship between parathyroid hormone(PTH) level and permanent hypoparathyroidism(PHPP) on the first day after radical papillary thyroidectomy, and its predictive value. Methods:A total of 80 patients with papillary thyroid cancer who underwent total thyroid resection and central lymph node dissection were collected and analyzed from January 2021 to January 2022. According to whether PHPP occurred after surgery, the patients were divided into hypoparathyroidism group and normal parathyroid function group, and univariate and binary logistics regression were used to analyze the correlation between PTH and serum calcium levels and PHPP on the first day after surgery in two groups. The dynamic changes of PTH at different time points after operation were analyzed. The area under the receiver operating characteristic was used to evaluate the predictive power of PTH on the development of PHPP after surgery. Results:Among the 80 patients with papillary thyroid cancer, 10 cases developed PHPP, with an incidence rate of 12.5%. Binary logistics regression analysis showed that PTH on the first postoperative day(OR=14.534, 95%CI: 2.377-88.858, P=0.004) was an independent predictive risk factor for postoperative PHPP. Taking PTH=8.75 ng/L on the first postoperative day as the cut-off value, the AUC of the area under the curve was 0.874(95%CI: 0.790-0.958, P<0.001), the sensitivity was 71.4%, the specificity was 100%, and the Yoden index was 0.714. Conclusion:PTH level on the first day after total thyroid papillary carcinoma surgery is closely related to PHPP, and is an independent predictor of PHPP.
Humans
;
Calcium
;
Hypoparathyroidism/surgery*
;
Parathyroid Glands
;
Parathyroid Hormone
;
Postoperative Complications/surgery*
;
Thyroid Cancer, Papillary/surgery*
;
Thyroid Neoplasms/complications*
;
Thyroidectomy
3.Clinical and genetic analysis of a newborn with hypoparathyroidism, sensorineural hearing loss, and renal dysplasia syndrome.
Qiaoyan SHAO ; Peilin WU ; Biyun LIN ; Senjing CHEN ; Jian LIU ; Suqing CHEN
Chinese Journal of Medical Genetics 2022;39(2):222-226
OBJECTIVE:
To analyze the clinical phenotype and genetic basis for a male neonate featuring hypoparathyroidism, sensorineural hearing loss, and renal dysplasia (HDR) syndrome.
METHODS:
The child was subjected to genome-wide copy number variation (CNVs) analysis and whole exome sequencing (WES). Clinical data of the patient was analyzed. A literature review was also carried out.
RESULTS:
The patient, a male neonate, had presented with peculiar facial appearance, simian crease and sacrococcygeal mass. Blood test revealed hypocalcemia, hypoparathyroidism. Hearing test suggested bilateral sensorineural deafness. Doppler ultrasound showed absence of right kidney. Copy number variation sequencing revealed a 12.71 Mb deletion at 10p15.3-p13 (chr10: 105 001_12 815 001) region. WES confirmed haploinsufficiency of the GATA3 gene. With supplement of calcium and vitamin D, the condition of the child has improved.
CONCLUSION
The deletion of 10p15.3p13 probably underlay the HDR syndrome in this patient.
DNA Copy Number Variations
;
Hearing Loss, Sensorineural/genetics*
;
Humans
;
Hypoparathyroidism/genetics*
;
Infant, Newborn
;
Kidney/abnormalities*
;
Male
;
Syndrome
;
Urogenital Abnormalities/genetics*
4.Hypoparathyroidism in a Case of Transfusion Dependent Thalassemia
Journal of the ASEAN Federation of Endocrine Societies 2020;35(1):129-132
Repeated blood transfusions in transfusion dependent thalassemia (TDT) leads to iron overload-related endocrine complications. Hypoparathyroidism (HPT) with severe signs of hypocalcemia is a recognized complication among these patients. A 14-year-old thalassaemic boy, on regular transfusion and on anticonvulsant therapy with a presumptive diagnosis of epilepsy for the last 1 year, was admitted with high fever and severe muscle cramps with positive Trousseau’s sign. He was diagnosed as a case of primary HPT and magnesium deficiency on the basis of low serum calcium, high phosphate, normal alkaline phosphates, very low intact parathyroid hormone (iPTH), normal serum vitamin D and very low serum magnesium level. His calcium, magnesium and phosphate level normalised following treatment with intravenous magnesium and calcium. His iPTH improved but remained at low normal. He was discharged from hospital with oral calcium, calcitriol, and magnesium supplementation. The anticonvulsant (Phenobarbitone) was successfully withdrawn gradually over the next six months without any recurrence of seizure in the subsequent 3 years of follow up. Acquired HPT (apparently from hemosiderosis) is a common cause of hypocalcemia; and magnesium depletion further complicated the situation leading to severe hypocalcemia with recurrent episodes of convulsion. Magnesium replacement improved the parathyroid hormone (PTH) value proving its role in acquired HPT. Very high phosphate level on admission and poor PTH response with respect to the low serum calcium, indicates intrinsic parathyroid pathology. Metabolic abnormalities should always be evaluated in thalassaemic subject with seizure disorder and it appears that the initial convulsive episodes were due to hypocalcemia. Muscle pain, cramps or convulsion may occur from HPT and simultaneous magnesium deficiency in transfusion dependent thalassaemic subjects. Metabolic correction is more important than anticonvulsant medication. Calcium and magnesium should both be assessed routinely in transfusion dependent thalassemic patients.
Hemosiderosis
;
Hypoparathyroidism
;
Thalassemia
5.Routine low-dose calcium supplementation after thyroidectomy does not reduce the rate of symptomatic hypocalcemia: a prospective randomized trial
Jun Woo LEE ; Jong Kyu KIM ; Hyungju KWON ; Woosung LIM ; Byung In MOON ; Nam Sun PAIK
Annals of Surgical Treatment and Research 2019;96(4):177-184
PURPOSE: Routine supplementation of high-dose calcium significantly decreased the risk of postoperative symptomatic hypocalcemia after thyroidectomy. However, there is an ongoing debate about whether the same results can be achieved with low-dose calcium supplementation. METHODS: Patients (n = 138) who underwent total thyroidectomy for thyroid cancer were 1:1 randomly assigned to receive oral supplements of 1,500 mg/day elemental calcium and 1,000 IU/day cholecalciferol for 2 weeks or no supplementation. Primary objective was to compare the incidence of symptomatic hypocalcemia for 3 days after total thyroidectomy. Secondary objective was to find the predictors for postoperative hypocalcemia in patients with thyroid cancer. RESULTS: Sixty-five patients in the calcium group and 69 patients in the control group were finally analyzed. The incidence of symptomatic hypocalcemia showed no difference between the calcium and control group (32.3% vs. 21.7%, P = 0.168). The total dosage of intravenous calcium (593.4 ± 267.1 mg vs. 731.6 ± 622.7 mg, P = 0.430) administered to patients with symptomatic hypocalcemia was also comparable between groups. In a multivariate analysis, parathyroid hormone level of 13 pg/mL at postoperative day 1 was only predictive for symptomatic hypocalcemia, and its incidence was 20.9 times (95% confidence interval, 6.8–64.5) higher in patients with parathyroid hormone <13 pg/mL. Other factors did not predict the development of hypocalcemia, including clinicopathological features and routine supplementation of low-dose calcium. CONCLUSION: Routine low-dose calcium supplementation did not reduce the risk of postoperative hypocalcemia. Patients who may benefit from calcium supplementation should be carefully selected.
Calcium
;
Cholecalciferol
;
Humans
;
Hypocalcemia
;
Hypoparathyroidism
;
Incidence
;
Multivariate Analysis
;
Parathyroid Hormone
;
Prospective Studies
;
Thyroid Neoplasms
;
Thyroidectomy
6.A novel compound heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrine syndrome type 1
Junghwan SUH ; Han Saem CHOI ; Ahreum KWON ; Hyun Wook CHAE ; Jin Sung LEE ; Ho Seong KIM
Annals of Pediatric Endocrinology & Metabolism 2019;24(4):248-252
Autoimmune polyendocrine syndrome type 1 (APS-1), or autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy is a rare, autosomal recessive autoimmune disease caused by a mutation of the autoimmune regulator (AIRE) gene. The main symptom triad in APS-1 comprises chronic mucocutaneous candidiasis, adrenal insufficiency, and hypoparathyroidism. Various autoimmune diseases and ectodermal abnormalities are also commonly associated with the syndrome. The treatment of APS-1 includes hormone replacement and symptom control. It is important to monitor such patients for clinical manifestations of their disease through regular follow-up. We report the case of a 10-year-old Korean girl with APS-1 due to a novel compound heterozygous mutation of the AIRE gene. This patient's main clinical manifestations were adrenal insufficiency and chronic mucocutaneous candidiasis. The patient had a previously known pathogenic variant of c.1513delG (p.Ala505ProfsTer16), and a newly discovered variant of c.1360dupC (p.His454ProfsTer50).
Adrenal Insufficiency
;
Autoimmune Diseases
;
Candidiasis, Chronic Mucocutaneous
;
Child
;
Ectoderm
;
Female
;
Follow-Up Studies
;
Humans
;
Hypoparathyroidism
;
Polyendocrinopathies, Autoimmune
7.Risk factors for hypoparathyroidism after thyroidectomy.
Wenlong WANG ; Xinying LI ; Fada XIA ; Ning BAI ; Zhejia ZHANG
Journal of Central South University(Medical Sciences) 2019;44(3):315-321
To investigate the risk factors for hypoparathyroidism after thyroidectomy.
Methods: Clinical data of 492 patients, who underwent thyroidectomy from April 2015 to December 2016 from Xiangya Hospital of Central South University, were studied retrospectively. Chi-square test and multivariable logistic regression were performed to find the risk factors for postoperative hypoparathyroidism.
Results: The incidence of postoperative hypoparathyroidism was 43.5%, and the incidence of temporary and permanent hypoparathyroidism was 43.1% and 0.4%, respectively. Univariate analysis showed that tumor pathology, thyroidectomy types, the extent of lymph node dissection, application of carbon nanoparticles, and merged Hashimoto's thyroiditis were risk factors for postoperative hypoparathyroidism (all P<0.01). Logistic regression analysis showed that: thyroidectomy types (OR=0.149, 95% CI 0.078 to 0.28), the extent lymph node dissection (OR=0.779, 95% CI 0.617 to 0.983) and application of carbon nanoparticles (OR=1.729,
95% CI 1.067 to 2.801) were independent risk factors for postoperative hypoparathyroidism (all P<0.05).
Conclusion: Hypoparathyroidism is a common complication after thyroidectomy. The incidence of postoperative hypoparathyroidism is significantly increased in patients underwent total thyroidectomy and cervical lymph node dissection. Application of carbon nanoparticles intraoperatively can reduce the incidence of postoperative hypoparathyroidism.
Humans
;
Hypoparathyroidism
;
surgery
;
Postoperative Complications
;
Retrospective Studies
;
Risk Factors
;
Thyroid Neoplasms
;
Thyroidectomy
8.Symptomatic Hypocalcemia Associated with Dioscorea tokoro Toxicity
Jae Chol YOON ; Jae Baek LEE ; Tae Oh JEONG ; Si On JO ; Young Ho JIN
Journal of The Korean Society of Clinical Toxicology 2019;17(1):42-45
Dioscorea tokoro has long been used in Korean traditional medicine as a pain killer and anti-inflammatory agent. A 53-year-old male who consumed water that had been boiled with raw tubers of D. tokoro as tea presented with numbness and spasm of both hands and feet. Laboratory results showed hypocalcemia, hypoparathyroidism, and vitamin D insufficiency. During his hospital stay, colitis, acute kidney injury, and toxic encephalopathy developed. The patient received calcium gluconate intravenous infusion and oral calcium carbonate with alfacalcidol. His symptoms improved gradually, but hypocalcemia persisted despite the calcium supplementation. We suggest that ingestion of inappropriately prepared D. tokoro can cause symptomatic hypocalcemia in patients with unbalanced calcium homeostasis.
Acute Kidney Injury
;
Calcium
;
Calcium Carbonate
;
Calcium Gluconate
;
Colitis
;
Dioscorea
;
Eating
;
Foot
;
Hand
;
Homeostasis
;
Humans
;
Hypesthesia
;
Hypocalcemia
;
Hypoparathyroidism
;
Infusions, Intravenous
;
Length of Stay
;
Male
;
Medicine, Korean Traditional
;
Middle Aged
;
Neurotoxicity Syndromes
;
Spasm
;
Tea
;
Vitamin D
;
Water
9.A Case of Transoral Endoscopic Thyroidectomy Combined with Facelift Modified Radical Neck Dissection
Myung Jun LEE ; Mi Ra KIM ; Jun Ook PARK
Korean Journal of Otolaryngology - Head and Neck Surgery 2019;62(6):343-346
We recently experienced a case of transoral endoscopic thyroidectomy combined with a modified radical neck dissection (MRND) using a facelift approach in a patient with keloid-prone skin. A 35-year-old female was diagnosed with a papillary thyroid carcinoma, which was 1.2 cm in diameter and showed level II-III lateral cervical metastases. The patient required total thyroidectomy and MRND; however, she was concerned about the neck incision because she had keloid-prone skin. We first performed a transoral, endoscopic total thyroidectomy combined with bilateral central node dissection via a tri-vestibular approach, and then followed it by MRND (II-V) using a facelift approach with the Da Vinci robotic system. We noted no significant complications, such as vocal cord palsy, hypoparathyroidism, or permanent loss of the lower lip or auricle. This new method of combining transoral and facelift approaches will be useful for patients with small thyroid cancers and lateral neck metastases.
Adult
;
Female
;
Humans
;
Hypoparathyroidism
;
Lip
;
Methods
;
Neck
;
Neck Dissection
;
Neoplasm Metastasis
;
Rhytidoplasty
;
Skin
;
Thyroid Neoplasms
;
Thyroidectomy
;
Vocal Cord Paralysis
10.Aluminum toxicity to bone: A multisystem effect?
Osteoporosis and Sarcopenia 2019;5(1):2-5
Aluminum (Al) is the third most abundant element in the earth's crust and is omnipresent in our environment, including our food. However, with normal renal function, oral and enteral ingestion of substances contaminated with Al, such as antacids and infant formulae, do not cause problems. The intestine, skin, and respiratory tract are barriers to Al entry into the blood. However, contamination of fluids given parenterally, such as parenteral nutrition solutions, or hemodialysis, peritoneal dialysis or even oral Al-containing substances to patients with impaired renal function could result in accumulation in bone, parathyroids, liver, spleen, and kidney. The toxic effects of Al to the skeleton include fractures accompanying a painful osteomalacia, hypoparathyroidism, microcytic anemia, cholestatic hepatotoxicity, and suppression of the renal enzyme 25-hydroxyvitamin D-1 alpha hydroxylase. The sources of Al include contamination of calcium and phosphate salts, albumin and heparin. Contamination occurs either from inability to remove the naturally accumulating Al or from leeching from glass columns used in compound purification processes. Awareness of this long-standing problem should allow physicians to choose pharmaceutical products with lower quantities of Al listed on the label as long as this practice is mandated by specific national drug regulatory agencies.
Aluminum
;
Anemia
;
Antacids
;
Calcium
;
Eating
;
Glass
;
Heparin
;
Humans
;
Hypoparathyroidism
;
Infant Formula
;
Intestines
;
Kidney
;
Leeching
;
Liver
;
Osteomalacia
;
Parathyroid Glands
;
Parenteral Nutrition Solutions
;
Peritoneal Dialysis
;
Pharmaceutical Preparations
;
Renal Dialysis
;
Respiratory System
;
Salts
;
Skeleton
;
Skin
;
Spleen


Result Analysis
Print
Save
E-mail